Soleno Therapeutics (SLNO) Debt Ratio (2013 - 2026)

Soleno Therapeutics (SLNO) has 5 years of Debt Ratio data on file, last reported at 0.08 in Q1 2026.

• On a quarterly basis, Debt Ratio fell 47.68% year-over-year to 0.08 in Q1 2026; TTM through Mar 2026 was 0.08, a 47.68% decrease from a year earlier, with the FY2025 full-year figure at 0.09, down 41.26% from the prior year.
• Debt Ratio for Q1 2026 stood at 0.08, down from 0.09 in the prior quarter.
• Over the last five years, Debt Ratio for SLNO reached as high as 0.16 in Q1 2025 and fell as low as 0.08 in Q1 2026.
• Historically, Debt Ratio has averaged 0.12 across 3 years, with a median of 0.12 in 2025.
• Across the five-year window, Debt Ratio slumped 41.26% in 2025 and tumbled 47.68% in 2026, its largest moves.
• Year by year, Debt Ratio stood at 0.15 in 2024, then slumped by 41.26% to 0.09 in 2025, then retreated by 7.31% to 0.08 in 2026.
• Per Business Quant data, the three most recent Debt Ratio figures were 0.08 in Q1 2026, 0.09 in Q4 2025, and 0.08 in Q3 2025.